Skip to main content

Advertisement

Log in

Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression

  • Original Article – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Long non-coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is reported to be dysregulated in hepatocellular carcinoma (HCC) progression. However, the functions of UCA1 in HCC still need further study. The aim is to detect the role of UCA1 involving in HCC cells proliferation and invasion, and epithelial–mesenchymal transition (EMT).

Methods

The quantitative real-time PCR was used to detect the UCA1 and miR-203 expression levels in 60 cases’ HCC tissues and adjacent normal tissues. Western blotting analysis was performed to detect the EMT markers E-cadherin, Vimentin and transcription factor Snail1, Snail2 expression. Luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays were used to evaluate whether miR-203 was a target of UCA1.

Results

Our results showed that UCA1 was markedly upregulated in HCC tissues and higher UCA1 expression in HCC was positively associated with tumor size, vascular invasion and American Joint Committee on Cancer (AJCC) stage (P < 0.05). Furthermore, gain-of-function and loss-of-function analysis showed that UCA1 knockdown inhibited HCC cells proliferation and invasion in vitro and xenograft tumour growth in vivo. Moreover, UCA1 overexpression promoted cell epithelial–mesenchymal transition (EMT) in HCC via effectively sponging to miR-203 and thereby activating the expression of transcription factor Snail2.

Conclusions

Our results identified that UCA1/miR-203/Snail2 pathway might involve in HCC progression. Inhibition of UCA1 acted as a promising therapeutic target for HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Bian Z, Jin L, Zhang J et al (2016) LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep 6:23892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng N, Cai W, Ren S et al (2015) Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer. Oncotarget 6:23582–23593

    Article  PubMed  PubMed Central  Google Scholar 

  • Dhanasekaran R, Limaye A, Cabrera R (2012) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med 4:19–37

    PubMed  PubMed Central  Google Scholar 

  • Ding X, Park SI, McCauley LK et al (2013) Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288:10241–10253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ergun S, Oztuzcu S (2015) Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways. Tumour Biol 36:3129–3136

    Article  CAS  PubMed  Google Scholar 

  • Gallicchio R, Nardelli A, Mainenti P et al (2016) Therapeutic strategies in HCC: radiation modalities. Biomed Res Int 2016:1295329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao J, Cao R, Mu H (2015) Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Pathol 8:12936–12942

    PubMed  PubMed Central  Google Scholar 

  • Giannelli G, Koudelkova P, Dituri F et al (2016) Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol 65:798–808. doi:10.1016/j.jhep.2016.05.007

    Article  CAS  PubMed  Google Scholar 

  • Gu Y, Chen T, Li G et al (2015) LncRNAs: emerging biomarkers in gastric cancer. Future Oncol 11:427–2441

    Article  Google Scholar 

  • Huarte M (2015) The emerging role of lncRNAs in cancer. Nat Med 21:1253–1261

    Article  CAS  PubMed  Google Scholar 

  • Jiping Z, Ming F, Lixiang W et al (2013) MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2. J Cell Biochem 114:2666–2672

    Article  PubMed  Google Scholar 

  • Karginov FV, Conaco C, Xuan Z et al (2007) A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 104:19291–19296

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lai MC, Yang Z, Zhou L et al (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29:1810–1816

    Article  CAS  PubMed  Google Scholar 

  • Li W, Jiang G, Zhou J et al (2014a) Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 34:1466–1476

    Article  CAS  PubMed  Google Scholar 

  • Li Z, Chao TC, Chang KY et al (2014b) The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111:1002–1007

    Article  CAS  PubMed  Google Scholar 

  • Lu Z, Xiao Z, Liu F et al (2016) Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1). Oncotarget 7:241–254

    PubMed  Google Scholar 

  • Maluccio M, Covey A (2012) Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 62:394–399

    Article  PubMed  Google Scholar 

  • Morise Z, Kawabe N, Tomishige H et al (2014) Recent advances in the surgical treatment of hepatocellular carcinoma. Front Surg 16:1–21

    Google Scholar 

  • Na XY, Liu ZY, Ren PP et al (2015) Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med 8:12609–12616

    PubMed  PubMed Central  Google Scholar 

  • Ni B, Yu X, Guo X et al (2015) Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 47:1329–1338

    CAS  PubMed  Google Scholar 

  • Nie W, Ge HJ, Yang XQ et al (2016) LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett 371:99–106

    Article  CAS  PubMed  Google Scholar 

  • Song W, Gobe GC (2016) Understanding molecular pathways and targets of Brachyury in epithelial-mesenchymal transition (EMT) in human cancers. Curr Cancer Drug Targets 16:586–593

    Article  CAS  PubMed  Google Scholar 

  • Srivastava AK, Singh PK, Rath SK et al (2014) Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder. Tumour Biol 35:11435–11442

    Article  CAS  PubMed  Google Scholar 

  • Wang F, Ying HQ, He BS et al (2015) Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6:7899–7917

    Article  PubMed  PubMed Central  Google Scholar 

  • Xiao C, Wu CH, Hu HZ (2016) LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 20:2819–2824

    CAS  PubMed  Google Scholar 

  • Xue M, Pang H, Li X et al (2016) Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci 107:18–27

    Article  PubMed  Google Scholar 

  • Yang T, Chen M, Sun T (2013) Simvastatin attenuates TGF-beta1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cell Physiol Biochem 31:863–874

    Article  CAS  PubMed  Google Scholar 

  • Yuan JH, Yang F, Wang F et al (2014) A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 25:666–681

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Cao X, Zhang L et al (2016) UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol 77:629–634

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thanks for Department of Pathology of First Clinical Medical College of Fujian Medical University for its generous help. This research was supported by Foundation of LongYan Medical Science and Technique Key Program (Grant No. 2013LY57).

Author contributions

T-HY and J-HJ contributed in study concept and design, execution of experiments and writing of the manuscript. RMY, YG, and W-LZ performed statistical analysis and interpretation of data. S-WL, H-XQ, and Z-PL collected tissue samples and clinical data and performed the experiments. J-NX, T-HY and J-HJ revised the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jin-Hua Jiang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

The study was approved by the Local Ethical Committee of Longyan Humanity Hospital (Longyan, Fujian, China) and complied with the Declaration of Helsinki. All procedures performed in this study were in accordance with the 1964 Helsinki Declaration and its later amendments.

Informed consent

Written informed consent was obtained from all patients included in the study.

Additional information

J.-N. Xiao and T.-H. Yan are contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, JN., Yan, TH., Yu, RM. et al. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J Cancer Res Clin Oncol 143, 981–990 (2017). https://doi.org/10.1007/s00432-017-2370-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-017-2370-1

Keywords

Navigation